MENU
KRRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Korro Bio (KRRO) Ownership - Who owns Korro Bio?
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases... Show more
Profile
Industry
N/A
Address
One Kendall Square
Phone
+1 617 468-1999
Employees
102
Web
https://www.korrobio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
151.94M
P/E Ratio
N/A
Total Cash
114.95M
Projected Growth
N/A
Total Debt
45.19M
Revenue
4.82M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
12.24
Total Debt/Equity
N/A
Revenue/Share
0.52 USD as % of share price
Fundamentals
KRRO
Capitalization
152M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
115M
Total Cash/Share
12.24
Total Debt
45.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.52%
Revenue
4.82M
ROE
N/A
Book Value
139M
P/B Ratio
1.09
Cash Flow
N/A
Earnings
-9.42
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
9.41
Current Revenue Per Employee
24519.23
Dividends Per Share - Security
N/A
EBITDA
-91.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-43.68
Shares Held By Institutions
357M
Shares Outstanding - Current
9.39M
Total Liabilities
63.2M
Total Volume MTD
N/A
Value
1
Gain YTD
-61.124
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Kendall Square
Phone
+1 617 468-1999
Employees
102
Web
https://www.korrobio.com